Babson Diagnostics’ Hybrid Model Combines Quality, Convenience

By Robert Michel | From the Volume XXIX, No. 16 – November 21, 2022 Issue

CEO SUMMARY: Responding to its own data about consumer preferences, healthcare technology company Babson Diagnostics is pursuing a new hybrid model for blood draws that it believes brings together the best of clinical laboratories and retail pharmacies. Laboratory managers and patho…

Read More

---

How Genomic Testing Labs Can Improve Their Relationships with Payers

By Robert Michel | From the Volume XXIX, No. 14 – October 10, 2022 Issue

CEO SUMMARY: For payers and health plans, it may be a matter of trust that initially curtails speedy reimbursement of new and novel genomic test claims. A panel …

Read More

---

Amazon to Close Employee COVID-19 Testing Lab in Ky.

By Robert Michel | From the Volume XXIX, No. 8 – June 6, 2022 Issue

IN A MOVE THAT MAY SURPRISE SOME OBSERVERS, Amazon announced it will close its COVID-19 employee testing laboratory in Hebron, Ky., which is just across the Ohio River from Cincinnati.  This is the second large COVID-19 clinical laboratory to publ…

Read More

---

Oracle’s $28b Cerner Deal Shows Value of Health Data

By Robert Michel | From the Volume XXIX, No. 2 – January 31, 2022 Issue

CEO SUMMARY: For three decades, pathologists and clinical lab executives regularly pointed out that clinical laboratory data was extremely valuable. But it seemed nothing changed, no one listened, and labs could not monetize their lab data. Now, one of Silicon Valley’s bigger play…

Read More

---

XIFIN’s Acquisition of OmniSYS Will Unite Lab with Pharmacy

By Robert Michel

This is an excerpt of a 1,829-word article in the January 10, 2022 issue of  THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: XIFIN’s acquisition of OmniSys, a pharmacy technology company, is the latest evidence that …

Read More

---

XIFIN Buys OmniSYS, Bridges Lab to Pharmacy

By Robert Michel | From the Volume XXIX, No. 1 – January 10, 2022 Issue

CEO SUMMARY: XIFIN’s acquisition of pharmacy technology company OmniSYS is the latest evidence that retail pharmacies are preparing to become a new front door to healthcare for consumers. The deal allows XIFIN to bring clinical lab information about patients directly to pharmacist…

Read More

---

New Class of IVD Firms Wants to Serve POCT in Near-Patient Settings

By Robert Michel | From the Volume XXVIII, No. 13 – September 27, 2021 Issue

CEO SUMMARY: Our second installment in this series describes an emerging new clas…

Read More

---

Amazon Now Interested in Home Testing Services

By Robert Michel | From the Volume XXVIII, No. 9 – July 6, 2021 Issue

CEO SUMMARY: In the past year, internet retailing giant Amazon has built sizeable clinical laboratories in the United States and the United Kingdom. Now it has regulatory clearance to sell a molecular COVID-19 test to consumers for home collection. Comments made in the past month by…

Read More

---

Amazon Makes Big Play into Health, Diagnostics

By Robert Michel | From the Volume XXVIII, No. 6 – May 3, 2021 Issue

CEO SUMMARY: Amazon is prepared to award $12 million in grants and is soliciting proposals for developing diagnostic technologies for detecting SARS-CoV-2 and other infectious diseases. This is the latest indication that the multi-billion-dollar enterprise would like to disrupt heal…

Read More

---

Amazon Sells COVID-19 Test Kit for At-Home Use by Consumers

By Robert Michel | From the Volume XXVIII No. 5 – April 12, 2021 Issue

QUIETLY AND WITHOUT MUCH ATTENTION, online retailing giant Amazon began to sell a COVID-19 molecular test to consumers for at-home testing. This is consistent with other actions Amazon has taken to generate revenue during the SARS-CoV-2 pandemic.  …

Read More

---